We have shown experimentally, for the first time, that Bcor can act as a tumour suppressor gene and the distinct gene-expression signature of Bcor-mutant lymphomas suggests that BCOR loss-of-function may subvert TGFβ signalling to drive lymphoma development. Here, TGFB1 is linked to lymphoma.